2015
DOI: 10.1016/j.antiviral.2015.04.015
|View full text |Cite
|
Sign up to set email alerts
|

AIM2 co-immunization favors specific multifunctional CD8+ T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 51 publications
0
17
0
Order By: Relevance
“…Three recent studies showed that immunization of mice against coxsackie virus B3 (CVB3) using AIM2 as a mucosal adjuvant had beneficial effects. Indeed compared to mice immunized with CVB3‐specific chitosan‐pVP1, co‐immunization of mice with CVB3‐chitosan‐pVP1 and chitosan‐pAIM2 conferred better resistance to CVB3‐induced myocarditits, increased secretory IgA, increased CVB3‐specific T cells responses and increased counts of CD8 + memory T cells …”
Section: Aim2 Detection Of Dnamentioning
confidence: 98%
“…Three recent studies showed that immunization of mice against coxsackie virus B3 (CVB3) using AIM2 as a mucosal adjuvant had beneficial effects. Indeed compared to mice immunized with CVB3‐specific chitosan‐pVP1, co‐immunization of mice with CVB3‐chitosan‐pVP1 and chitosan‐pAIM2 conferred better resistance to CVB3‐induced myocarditits, increased secretory IgA, increased CVB3‐specific T cells responses and increased counts of CD8 + memory T cells …”
Section: Aim2 Detection Of Dnamentioning
confidence: 98%
“…CS-pAIM2/CS-pVP1 vaccine alleviate the CVB3-induced acute myocarditis (Chai et al, 2014). We also have demonstrated that CS-pAIM2/CS-pVP1 vaccine alleviate the CVB3-induced chronic myocarditis by enhancing the immunogenicity of immunogenic antigens and efficiently inducing mucosal T cell immune responses with intranasal immunization (Chai et al, 2015). In the present study, the results show that AIM2 co-immunization with VP1 could mount long-lasting immune responses against acute viral myocarditis.…”
Section: Discussionmentioning
confidence: 99%
“…T cell reactivity against AIM2 has been found in patients with melanoma, suggesting that AIM2‐derived peptides are an ideal candidate for immunomonitoring 95 . Indeed, as a sensor of DNA, AIM2 induces an antigen‐specific antibody response and is used as an adjuvant to enhance therapeutic efficacy through CD8 + T cell adaptive immunity 39–42 . For example, AIM2 promotes the multifunctional CD8 + T cell activation elicited by the viral capsid protein 1 vaccine, 39 which favors long‐lasting protection against Coxsackievirus B 3 ‐induced myocarditis 40 .…”
Section: Role Of Aim2 In Immune Cellsmentioning
confidence: 99%